Results 201 to 210 of about 124,971 (293)

Engineered Microfluidic Organoid Systems: New Paradigms for Menopause Mechanism Research and Personalized Medicine

open access: yesAdvanced Materials Technologies, Volume 11, Issue 9, 6 May 2026.
This review explores the integration of microfluidic technology with organoid systems as an innovative platform for studying menopausea complex multi‐organ condition. By enabling precise simulation of inter‐organ communication and hormone responses, microfluidic organoids offer a physiologically relevant model for investigating menopausal syndrome and ...
Qianyi Zhang   +4 more
wiley   +1 more source

Correction: Metabolic state uncovers prognosis insights of esophageal squamous cell carcinoma patients. [PDF]

open access: yesJ Transl Med
Feng T   +9 more
europepmc   +1 more source

Immune Checkpoint Inhibitors and Immunomodulators for Cancer Immunotherapy: Insights Into Resistance and Therapeutic Strategies

open access: yesAdvanced Science, Volume 13, Issue 25, 4 May 2026.
The schematic diagram illustrates the roles of novel immune checkpoints, immunomodulatory factors, cell death and multimodal technologies in cancer immunotherapy. Abstract Cancer immunotherapy has redefined cancer treatment. However, the molecular and cellular basis of immune evasion and therapeutic resistance remains incompletely understood.
Fangquan Chen   +7 more
wiley   +1 more source

Relationship Between the Oral Microbiome and Treatment Efficacy in Esophageal Squamous Cell Carcinoma. [PDF]

open access: yesAnn Surg Oncol
Ohsawa M   +7 more
europepmc   +1 more source

Neoadjuvant Immunochemotherapy Increases the Abundance of Tertiary Lymphoid Structures and Lymphocyte Subpopulations Is Associated With Prognosis of Esophageal Squamous Cell Carcinoma

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Neoadjuvant immunochemotherapy (NIC) has emerged as a promising strategy for esophageal squamous cell carcinoma (ESCC). However, its impact on tertiary lymphoid structures (TLSs) and the immune microenvironment remains to be fully elucidated. We retrospectively analyzed 50 ESCC patients treated with NIC (n = 25) or chemotherapy alone (n = 25 ...
Ning Li   +7 more
wiley   +1 more source

Ubiquitin‐Specific Protease 45 Inhibits Lung Adenocarcinoma Ferroptosis by Regulating Ubiquitination and Stability of Glutathione Peroxidase 4

open access: yesCancer Medicine, Volume 15, Issue 5, May 2026.
ABSTRACT Lung adenocarcinoma is the most common subtype of lung cancer and the leading cause of cancer‐related mortality worldwide. Ferroptosis, a regulated form of cell death characterized by iron‐dependent lipid peroxidation, has emerged as a promising therapeutic target for lung adenocarcinoma.
Mingxiang Huang   +4 more
wiley   +1 more source

Dysphagia Revealing Pulmonary Squamous Cell Carcinoma: Successful Palliation With Esophageal Stenting in an Elderly Patient

open access: yesClinical Case Reports, Volume 14, Issue 5, May 2026.
Fluoroscopic control after deployement of a partially covered esophageal self‐expandable metallic stent (12.5 cm × 20 mm), demonstrating adequate expansion across the stenotic segment. ABSTRACT In elderly patients, a smooth concentric esophageal stricture with normal mucosa should raise suspicion of extraesophageal causes, prompting cross‐sectional ...
Mehdi Belaich   +7 more
wiley   +1 more source

Prior Cancer and Survival in Patients With Esophageal Squamous Cell Carcinoma.

open access: yesJAMA Netw Open
Yu S   +23 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy